LONDON STOCK EXCHANGE · AZN

+0.25% · +$0.4200 · Vol 3.1M

Market closed · last close 4:00 PM ET · price as of 19:02:24 ET

AstraZeneca PLC

Pharmaceuticals

$166.56

Card

Relationship Map

Follow $AZN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AZN by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · AZN

Methodology

AZN

AstraZeneca PLC

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

58/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100

Veridion Score

Middle range · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is AZN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move AZN next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Sep 18
Score
Score moved -10
68/Upper range -> 58/Middle range
Veridion score historySource
Mar 31
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 30
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 18
CongressChecking access
Gilbert Ray Cisneros, Jr. purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 8
CongressChecking access
Julia Letlow purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Nov 19
CongressChecking access
Gilbert Ray Cisneros, Jr. purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 31
CongressChecking access
Lisa C. McClain sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 30
CongressChecking access
Lisa C. McClain sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 30
CongressChecking access
Lisa C. McClain purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About AstraZeneca PLC

Pharmaceuticals

Listed since

2009

Employees

96K

Country

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$167.15

Day high

$167.83

Day low

$165.54

Previous close

$166.14

52W high

$209.48

-20.49% from high

52W low

$147.06

31% of range

Market cap

$257.6B

P/E

24.72×

EPS

$6.69

Beta

-0.34

Shares out

1.6B

Volume

3.1M

0.92× rel vol

Avg volume

3.3M

VWAP

$166.46

Price history computed in-house

+1.70%

+0.35%

-7.99%

+9.18%

YTD

-9.41%

SMA 50 $164.27 · above

SMA 200 $182.98 · below

52W position 31%

AZN overview

Veridion Score

Registered · 2026-09-18

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around AZN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

AZN insider activity

AstraZeneca PLC

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the receipt-backed Form 4 snapshot could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not evaluated: the receipt-backed Form 4 snapshot could not be read.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in AZN

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AZN in the cached public ledger.

Federal contracts

AZN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for AZN in this window.

Lobbying spend

AZN lobbying filings, year to date.

Registered lobbying filings matched to AstraZeneca PLC.

$4.8M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Medicare/MedicaidHealth Issues Medicare/Medicaid Pharmacy Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign) Labor Issues/Antitrust/Workplace Taxation/Internal Revenue CodeHealth Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)

Filing

$2.3M

ASTRAZENECA PHARMACEUTICALS LP

Apr 20, 2026

Filing

$1.7M

ASTRAZENECA PHARMACEUTICALS LP

Jul 20, 2026

Filing

$670.0K

ASTRAZENECA PHARMACEUTICALS LP

Jan 20, 2026